BHM.F Bachem Holding AG

Healthcare Chemicals Frankfurt Exchange
10.20 EUR
Close of Nov 12, 2026
4.54 10.20
Market cap
EUR 7.64B
P/E
48.6x
P/B
4.87x
ROE
10.2%
Dividend yield
0.97%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is BHM.F undervalued?

Graham number

The Graham number of Bachem Holding AG cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bachem Holding AG fundamental analysis

No fundamental analysis for Bachem Holding AG yet.

Bachem Holding AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical…

Full company profile